Virax Biolabs Group Limited (VRAX)
Nasdaq: VRAX · In Vitro & In Vivo Diagnostic Substances · Lanarkshire, GB · filing with the SEC since 2021
Who runs Virax Biolabs Group Limited
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Foster James Alexander Cunliffe
Chief Executive Officer. First filing Mar 2026, latest Mar 18, 2026, 0 filings in all.
Officers reporting now
3
of 6 people with a filing in the last fifteen months
Directors reporting now
3
6 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Mccracken Nigel William | Chief Operating Officer | Mar 2026 | Mar 20, 2026 | none |
| Foster James Alexander Cunliffe | Chief Executive Officer | Mar 2026 | Mar 18, 2026 | none |
| Davis Jason | Chief Financial Officer | Mar 2026 | Mar 18, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Haight Nelson M | director | Mar 2026 | Mar 31, 2026 | none |
| Miller Iain David | director | Mar 2026 | Mar 18, 2026 | none |
| Norton Evan Michael | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.